Medical Research Foundation, Oregon
15
1
2
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
20.0%
3 terminated/withdrawn out of 15 trials
72.7%
-13.8% vs industry average
7%
1 trials in Phase 3/4
88%
7 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
The Influence of Sleep on Cardiovascular Outcomes
Role: collaborator
Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer
Role: collaborator
Aerobic Exercise for Remyelination in Multiple Sclerosis
Role: collaborator
Can Early Initiation of Rehabilitation With Wearable Sensor Technology Improve Outcomes in mTBI?
Role: collaborator
Y-90 Versus SBRT for Inoperable HCC
Role: collaborator
M-gCBT for Women With Provoked Localized Vulvodynia
Role: collaborator
Pregnancy and Latent Labor Biomarkers and Symptoms to Predict Cervical Dilation at Hospital Admission.
Role: collaborator
Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil
Role: collaborator
Thrombelastography Based Dosing of Enoxaparin
Role: collaborator
Acupuncture for Sedation in the Intensive Care Unit (ICU)
Role: collaborator
Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer
Role: collaborator
Emergency Contraception and Body Weight: Pilot Study
Role: collaborator
Relationship Between the Menstrual Cycle and Heart Disease in Women
Role: collaborator
Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response
Role: collaborator
Morbidity and Mortality Among Dialysis Patients After Treatment for Depression
Role: collaborator
All 15 trials loaded